Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Drug Discovery Today|August 31, 2010
PET tracers for the peripheral benzodiazepine receptor and uses thereofPernilla J Schweitzer, Brian A Fallon, J John Mann, et al.Journal of Psychosomatic Research|September 25, 2016
Avoidance in hypochondriasisEmily R Doherty-Torstrick, Kate E Walton, Arthur J Barsky, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|August 21, 2003
Regional cerebral blood flow and cognitive deficits in chronic lyme diseaseBrian A Fallon, John Keilp, Isak Prohovnik, et al.Psychosomatics|April 3, 2018
Depressive Symptoms and Suicidal Ideation Among Symptomatic Patients With a History of Lyme Disease vs Two Comparison GroupsShreya Doshi, John G Keilp, Barbara Strobino, et al.Frontiers in Medicine|April 23, 2025
A pilot study of disulfiram for individuals with persistent symptoms despite prior antibiotic treatment for Lyme diseaseMara Kuvaldina, Jessica Preston, Denise McClellan, et al.Antibiotics (Basel, Switzerland)|March 29, 2023
Disulfiram: Mechanisms, Applications, and ChallengesJenna Lanz, Nicholas Biniaz-Harris, Mara Kuvaldina, et al.Journal of Neuroimmunology|November 13, 2012
Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficitsElzbieta Jacek, Brian A Fallon, Abhishek Chandra, et al.Psychosomatics|January 21, 2016
The Relationship of Hypochondriasis to Anxiety, Depressive, and Somatoform DisordersTimothy M Scarella, Johannes A C Laferton, David K Ahern, et al.Frontiers in Neurology|May 27, 2021
Detecting Borrelia Spirochetes: A Case Study With Validation Among Autopsy SpecimensShiva Kumar Goud Gadila, Gorazd Rosoklija, Andrew J Dwork, et al.The American Journal of Psychiatry|June 30, 2017
A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for HypochondriasisBrian A Fallon, David K Ahern, Martina Pavlicova, et al.Pageof 6